PRCP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.21059999996987E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.0276999999892E-06 |
Normal-vs-Stage2 |
4.085800E-01 |
Normal-vs-Stage3 |
6.415000E-04 |
Normal-vs-Stage4 |
3.621500E-03 |
Stage1-vs-Stage2 |
7.107600E-02 |
Stage1-vs-Stage3 |
7.384600E-01 |
Stage1-vs-Stage4 |
9.554600E-01 |
Stage2-vs-Stage3 |
9.592200E-02 |
Stage2-vs-Stage4 |
2.605400E-01 |
Stage3-vs-Stage4 |
8.762000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.50679999999515E-06 |
Normal-vs-AfricanAmerican |
2.126100E-02 |
Normal-vs-Asian |
5.245400E-01 |
Caucasian-vs-AfricanAmerican |
1.716150E-01 |
Caucasian-vs-Asian |
6.330600E-01 |
AfricanAmerican-vs-Asian |
9.925000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
5.99610000540096E-08 |
Normal-vs-Female |
2.194000E-01 |
Male-vs-Female |
5.763000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.558680E-04 |
Normal-vs-Extreme_Weight |
2.6003999953339E-08 |
Normal-vs-Obese |
6.576700E-03 |
Normal-vs-Extreme_Obese |
6.267900E-02 |
Normal_Weight-vs-Extreme_Weight |
4.954200E-01 |
Normal_Weight-vs-Obese |
4.064400E-01 |
Normal_Weight-vs-Extreme_Obese |
5.344400E-01 |
Extreme_Weight-vs-Obese |
1.043830E-01 |
Extreme_Weight-vs-Extreme_Obese |
7.973400E-01 |
Obese-vs-Extreme_Obese |
3.314400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.246800E-01 |
Normal-vs-Age(41-60Yrs) |
5.58199999999287E-05 |
Normal-vs-Age(61-80Yrs) |
1.50169999999505E-05 |
Normal-vs-Age(81-100Yrs) |
8.096400E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.503600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.799000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.389400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.057600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.240400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.516200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.43900000004749E-06 |
Normal-VS-Type2 PRCC |
7.80650000000715E-05 |
Normal-VS-KIRP CIMP |
8.496600E-01 |
Normal-VS-Unclassified PRCC |
2.648200E-01 |
Type1 PRCC-VS-Type2 PRCC |
9.819600E-01 |
Type1 PRCC-VS-KIRP CIMP |
7.855600E-02 |
Type1 PRCC-VS-Unclassified PRCC |
5.496100E-02 |
Type2 PRCC-VS-KIRP CIMP |
9.010000E-02 |
Type2 PRCC-VS-Unclassified PRCC |
9.265700E-02 |
KIRP CIMP-VS-Unclassified PRCC |
6.440200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.302800E-03 |
Normal-vs-N1 |
4.139500E-03 |
Normal-vs-N2 |
4.165000E-03 |
N0-vs-N1 |
7.450800E-01 |
N0-vs-N2 |
6.194200E-01 |
N1-vs-N2 |
6.798000E-01 |
|
|